Department of Surgery and Transplantations B, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
ANZ J Surg. 2022 Oct;92(10):2538-2543. doi: 10.1111/ans.17852. Epub 2022 Jun 22.
Most Crohn's Disease (CD) patients will require surgical intervention over their lifetime, with considerably high rates of post-operative complications. Risk stratification with reliable prognostic tools may facilitate clinical decision making in these patients. Blood cell interaction based inflammatory markers have proven useful in predicting patient outcomes in oncological and benign diseases. The aim of this study was to investigate their prognostic value in CD patients undergoing surgery.
A retrospective single institution study of CD patients who underwent surgery between the years 2008 and 2019 was conducted. Data were collected from medical records and analysed for association of Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR) and the modified Systemic Inflammatory Score (mSIS) with post-operative outcomes.
A total of 81 patients were included in the analysis. Half were females; mean age was 36 ± 15.54 years. Fifty seven percent (n = 46) were operated in expedited settings, with 23.5% developing post-operative complications. In elective patients, higher pre-operative NLR (P = 0.029) and PLR (P = 0.034) were associated with major post-operative complications, higher NLR (P = 0.029) and PLR (P = 0.034) were associated with re-operation and higher PLR correlated with Clavien-Dindo score (P = 0.032). In patients operated in expedited operations, higher pre-operative NLR (P = 0.021) and lower pre-operative LMR (P = 0.018) were associated with thromboembolic events and higher mSIS was associated with major post-operative complications (P = 0.032).
Blood cell interaction based inflammatory markers confer an association with post-operative complications in CD patients undergoing surgery. These indices may facilitate patient selection and optimization when considering the risks and benefits of surgical interventions.
大多数克罗恩病(CD)患者在其一生中都需要手术干预,且术后并发症发生率相当高。使用可靠的预后工具进行风险分层可能有助于这些患者的临床决策。基于血细胞相互作用的炎症标志物已被证明可用于预测肿瘤和良性疾病患者的预后。本研究旨在探讨其在接受手术的 CD 患者中的预后价值。
回顾性分析了 2008 年至 2019 年间在我院接受手术的 CD 患者的单中心研究。从病历中收集数据,并分析血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)和改良全身炎症评分(mSIS)与术后结果的相关性。
共纳入 81 例患者进行分析。女性占一半;平均年龄为 36±15.54 岁。57%(n=46)在紧急情况下进行手术,23.5%发生术后并发症。在择期手术患者中,较高的术前 NLR(P=0.029)和 PLR(P=0.034)与主要术后并发症相关,较高的 NLR(P=0.029)和 PLR(P=0.034)与再次手术相关,较高的 PLR 与 Clavien-Dindo 评分相关(P=0.032)。在紧急手术患者中,较高的术前 NLR(P=0.021)和较低的术前 LMR(P=0.018)与血栓栓塞事件相关,较高的 mSIS 与主要术后并发症相关(P=0.032)。
基于血细胞相互作用的炎症标志物与接受手术的 CD 患者的术后并发症相关。这些指标可能有助于在考虑手术干预的风险和益处时选择和优化患者。